Genetics and Outcome of Atypical Hemolytic Uremic Syndrome
Hôpital Européen Georges-Pompidou · Hôpital Européen
Abstract
BACKGROUND AND OBJECTIVES: Atypical hemolytic uremic syndrome (aHUS) is a rare complement-mediated kidney disease that was first recognized in children but also affects adults. This study assessed the disease presentation and outcome in a nationwide cohort of patients with aHUS according to the age at onset and the underlying complement abnormalities. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A total of 214 patients with aHUS were enrolled between 2000 and 2008 and screened for mutations in the six susceptibility factors for aHUS and for anti-factor H antibodies. RESULTS: Onset of aHUS occurred as frequently during adulthood (58.4%) as during childhood (41.6%). The percentages of patients who developed…
Citation impact
- FWCI
- 27.23
- Percentile
- 100%
- References
- 23
Authors
16- VFVéronique Frémeaux‐BacchiCorresponding
Hôpital Européen Georges-Pompidou, Hôpital Européen
- FFFádi Fakhouri
Hôpital Européen Georges-Pompidou, Hôpital Européen
- AGArnaud Garnier
Hôpital Européen Georges-Pompidou, Hôpital Européen
- FBFrank Bienaimé
Hôpital Européen Georges-Pompidou, Hôpital Européen
- MDMarie‐Agnès Dragon‐Durey
Hôpital Européen Georges-Pompidou, Hôpital Européen
Topics & keywords
- Medicine
- Atypical hemolytic uremic syndrome
- Internal medicine
- Intensive care medicine
- Pediatrics
- Immunology
- Antibody
- Complement system
- Good health and well-being